COCP
Companies
NASDAQ
Cocrystal Pharma Inc.
Health Care
$1.55
-$0.47 (-23.27%)
Price Chart
Overview
About COCP
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Market Cap
$25.7M
Volume
29.7K
Avg. Volume
26.4K
P/E Ratio
-0.5837104
Dividend Yield
0.00%
Employees
13.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.66
Low Correlation
Volatility
High (0.92)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, COCP shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$25.7M
Volume29.7K
P/E Ratio-0.58
Dividend Yield0.00%
Important Dates
Next Dividend
January 24, 2018Next Earnings
March 31, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025